These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1540641)

  • 1. Inhibition and inactivation of monoamine oxidase by 3-amino-1-phenyl-prop-1-enes.
    Williams CH; Lawson J; Backwell FR
    Biochim Biophys Acta; 1992 Feb; 1119(2):111-7. PubMed ID: 1540641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of 3-amino-1-phenylprop-1-enes by monoamine oxidase and their use in a continuous assay of the enzyme.
    Williams CH; Lawson J; Backwell FR
    Biochem J; 1988 Dec; 256(3):911-5. PubMed ID: 3223960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for reactivation of N-cyclopropylbenzylamine-inactivated monoamine oxidase by amines.
    Yamasaki RB; Silverman RB
    Biochemistry; 1985 Nov; 24(23):6543-50. PubMed ID: 4084537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised mechanism for inactivation of mitochondrial monoamine oxidase by N-cyclopropylbenzylamine.
    Vazquez ML; Silverman RB
    Biochemistry; 1985 Nov; 24(23):6538-43. PubMed ID: 4084536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inactivation of MAO-B by benzyl-dimethyl-silyl-methanamines in vitro.
    Danzin C; Collard JN; Marchal P; Schirlin D
    Biochem Biophys Res Commun; 1989 Apr; 160(2):540-4. PubMed ID: 2719680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts.
    Yu PH; Davis BA
    Int J Biochem Cell Biol; 1999 Dec; 31(12):1391-7. PubMed ID: 10641793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.
    Wang J; Edmondson DE
    Biochemistry; 2011 Apr; 50(13):2499-505. PubMed ID: 21341713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
    Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
    J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
    Youngster SK; McKeown KA; Jin YZ; Ramsay RR; Heikkila RE; Singer TP
    J Neurochem; 1989 Dec; 53(6):1837-42. PubMed ID: 2809594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based inactivation of mitochondrial monoamine oxidase by N-(1-methylcyclopropyl)benzylamine.
    Silverman RB; Yamasaki RB
    Biochemistry; 1984 Mar; 23(6):1322-32. PubMed ID: 6712946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
    Kinemuchi H; Sudo M; Yoshino M; Kawaguchi T; Sunami Y; Kamijo K
    Life Sci; 1983 Jan; 32(5):517-24. PubMed ID: 6823208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.
    O'Brien EM; Dostert P; Pevarello P; Tipton KF
    Biochem Pharmacol; 1994 Aug; 48(5):905-14. PubMed ID: 8093103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of structural modification of alkyl N-propargylamines on the selective inhibition of monoamine oxidase B activity.
    Yu PH; Davis BA; Boulton AA
    Biochem Pharmacol; 1993 Aug; 46(4):753-7. PubMed ID: 8363648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.